|
|
Volumn 535, Issue 7613, 2016, Pages 476-477
|
|
First trial of CRISPR in people: Chinese team approved to test gene-edited cells in people with lung cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
PDCD1 PROTEIN, HUMAN;
CANCER;
DISEASE TREATMENT;
GENETIC ANALYSIS;
GENETIC ENGINEERING;
RESEARCH WORK;
CANCER IMMUNOTHERAPY;
CANCER THERAPY;
CHINESE;
CHROMOSOME;
CRISPR CAS SYSTEM;
HUMAN;
NON SMALL CELL LUNG CANCER;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHINA;
DEFICIENCY;
EMBRYO RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GENE INACTIVATION;
GENETIC ENGINEERING;
GENETICS;
HAPLORHINI;
HIV INFECTIONS;
IMMUNOLOGY;
IMMUNOTHERAPY;
LUNG NEOPLASMS;
METABOLISM;
NATIONAL HEALTH ORGANIZATION;
PHASE 1 CLINICAL TRIAL (TOPIC);
PROCEDURES;
REPRODUCIBILITY;
T LYMPHOCYTE;
UNITED STATES;
CHINA;
ANIMALS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHINA;
CLINICAL TRIALS, PHASE I AS TOPIC;
CRISPR-CAS SYSTEMS;
EMBRYO RESEARCH;
GENE KNOCKOUT TECHNIQUES;
GENETIC ENGINEERING;
HAPLORHINI;
HIV INFECTIONS;
HUMANS;
IMMUNOTHERAPY;
LUNG NEOPLASMS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PROGRAMMED CELL DEATH 1 RECEPTOR;
REPRODUCIBILITY OF RESULTS;
T-LYMPHOCYTES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84982136632
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature.2016.20302 Document Type: Short Survey |
|
Times cited : (141)
|
|
References (0)
|
